30 related articles for article (PubMed ID: 12393524)
1. Serum interleukin-10 as a valuable biomarker for early diagnosis and therapeutic monitoring in intravascular large B-cell lymphoma.
Zhang Y; Wang L; Sun J; Wang W; Wei C; Zhou D; Zhang W
Clin Transl Med; 2020 Jul; 10(3):e131. PubMed ID: 32634257
[No Abstract] [Full Text] [Related]
2. Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study.
Chen Z; Du Z; Chen J; Chen Z; Bao Y; Tang F
Med Oncol; 2011 Mar; 28(1):241-8. PubMed ID: 20165991
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.
Tzankov A; Went P; Dirnhofer S
Biomark Insights; 2007 Nov; 2():403-17. PubMed ID: 19662221
[TBL] [Abstract][Full Text] [Related]
4. Primary splenic diffuse large B-cell lymphoma manifesting in red pulp.
Kashimura M; Noro M; Akikusa B; Okuhara A; Momose S; Miura I; Kojima M; Tamaru J
Virchows Arch; 2008 Nov; 453(5):501-9. PubMed ID: 18818942
[TBL] [Abstract][Full Text] [Related]
5. CD5+ diffuse large B-cell lymphoma consists of germline cases and hypermutated cases in the immunoglobulin heavy chain gene variable region.
Nakamura N; Nakamura S; Yamaguchi M; Ichinohasama R; Yoshino T; Kuze T; Sasaki Y; Yoshida S; Abe M
Int J Hematol; 2005 Jan; 81(1):58-61. PubMed ID: 15717690
[TBL] [Abstract][Full Text] [Related]
6. De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.
Kong SY; Cho EH; Woo HY; Park Q; Ko YH; Kim SH
J Korean Med Sci; 2004 Dec; 19(6):815-9. PubMed ID: 15608391
[TBL] [Abstract][Full Text] [Related]
7. Histogenesis of CD5-positive and CD5-negative B-cell neoplasms on the aspect of somatic mutation of immunoglobulin heavy chain gene variable region.
Nakamura N; Abe M
Fukushima J Med Sci; 2003 Dec; 49(2):55-67. PubMed ID: 15065636
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin V gene expression in CD5 B-cell malignancies.
Kipps TJ; Rassenti LZ; Duffy S; Johnson T; Kobayashi R; Carson DA
Ann N Y Acad Sci; 1992 May; 651():373-83. PubMed ID: 1376056
[TBL] [Abstract][Full Text] [Related]
9. Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas.
Kume M; Suzuki R; Yatabe Y; Kagami Y; Miura I; Miura AB; Morishima Y; Nakamura S; Seto M
Jpn J Cancer Res; 1997 Nov; 88(11):1087-93. PubMed ID: 9439684
[TBL] [Abstract][Full Text] [Related]
10. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
11. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation.
Taniguchi M; Oka K; Hiasa A; Yamaguchi M; Ohno T; Kita K; Shiku H
Blood; 1998 Feb; 91(4):1145-51. PubMed ID: 9454743
[TBL] [Abstract][Full Text] [Related]
12. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome).
Nakamura N; Kuze T; Hashimoto Y; Hoshi S; Tominaga K; Sasaki Y; Shirakawa A; Sato M; Maeda K; Abe M
Pathol Int; 2000 Aug; 50(8):636-43. PubMed ID: 10972862
[TBL] [Abstract][Full Text] [Related]
14. Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell.
Katzenberger T; Lohr A; Schwarz S; Dreyling M; Schoof J; Nickenig C; Stilgenbauer S; Kalla J; Ott MM; Müller-Hermelink HK; Ott G
Blood; 2003 Jan; 101(2):699-702. PubMed ID: 12393524
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
